For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) was $1.15 for the day, down -3.36% from the previous closing price of $1.19. In other words, the price has decreased by -$3.36 from its previous closing price. On the day, 0.84 million shares were traded. ADAP stock price reached its highest trading level at $1.23 during the session, while it also had its lowest trading level at $1.11.
Ratios:
Our analysis of ADAP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.85 and its Current Ratio is at 2.85. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Bryan Garnier on March 24, 2023, initiated with a Buy rating and assigned the stock a target price of $3.60.
On January 03, 2023, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
Mizuho Upgraded its Neutral to Buy on November 09, 2022, while the target price for the stock was maintained at $9.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 17 ’24 when Rawcliffe Adrian sold 30,080 shares for $0.67 per share. The transaction valued at 20,244 led to the insider holds 44,848 shares of the business.
Bertrand William C JR sold 18,908 shares of ADAP for $12,725 on Jan 17 ’24. The Chief Operating Officer now owns 7,785 shares after completing the transaction at $0.67 per share. On Jan 17 ’24, another insider, Norry Elliot, who serves as the Chief Medical Officer of the company, sold 18,276 shares for $0.67 each. As a result, the insider received 12,300 and left with 7,785 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADAP now has a Market Capitalization of 309501792 and an Enterprise Value of 1581390080. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.30 while its Price-to-Book (P/B) ratio in mrq is 6.61. Its current Enterprise Value per Revenue stands at 26.234 whereas that against EBITDA is -12.336.
Stock Price History:
Over the past 52 weeks, ADAP has reached a high of $2.05, while it has fallen to a 52-week low of $0.42. The 50-Day Moving Average of the stock is -15.52%, while the 200-Day Moving Average is calculated to be 27.45%.
Shares Statistics:
ADAP traded an average of 1.58M shares per day over the past three months and 862780 shares per day over the past ten days. A total of 227.17M shares are outstanding, with a floating share count of 215.86M. Insiders hold about 4.98% of the company’s shares, while institutions hold 50.24% stake in the company. Shares short for ADAP as of 1713139200 were 3407756 with a Short Ratio of 2.15, compared to 1710460800 on 3112390. Therefore, it implies a Short% of Shares Outstanding of 3407756 and a Short% of Float of 2.0.
